In a statement, our CTO & Co-founder, Simone Tognetti, describe how EmbraceMini was designed to address a gap in DHTs, where high data integrity and value meet unprecedented participant comfort:
At just 12mm thick and 14mm wide, EmbraceMini is the smallest wristworn actigraphy device for clinical research in the world–the size of a USB flash drive or AA battery. It is purpose-built for studies that monitor sleep and movement, featuring a long battery life that can achieve at least 7 days of continuous data collection via 4 high-frequency sensors: a 3-axis Accelerometer, a 3-axis Gyroscope, a 3-axis Magnetometer, and an Ambient Light sensor.
EmbraceMini can accurately and passively monitor over 200 digital sleep and activity measures, thanks to sophisticated algorithms developed by Empatica and its partners. Among other important metrics, EmbraceMini can track digital biomarkers across physical activity, sleep, gait, and light exposure, which can serve a key role as digital endpoints in studies monitoring sleep disorders, movement disorders, obesity, depression, pain, and more. EmbraceMini can also collect raw data, providing researchers with more transparency and flexibility in how they process information.
Thanks to Empatica’s modular approach, EmbraceMini can be worn on the wrist, leg, around the waist, or the ankle. Empatica also recently announced its double-device functionality, allowing the simultaneous collection of data from two devices worn by the same participant. With the arrival of EmbraceMini, researchers can combine data from Empatica’s flagship wearable EmbracePlus (including cardiorespiratory measures collected from its PPG sensor) and EmbraceMini, or two EmbraceMini devices, worn on different locations of the body.
Empatica Inc., 1 Broadway, 14th floor, Cambridge MA 02142 United States - Empatica Srl, Via Stendhal 36, 20144 Milano (MI), Italy
P. IVA IT07462810966. Copyright © 2026 Empatica Inc. - ISO 13485 Cert. No. 39050072201 - All rights reserved - Legal
